Log In
Print
BCIQ
Print
Print this Print this
 

LOR-253 (formerly LT-253)

  Manage Alerts
Collapse Summary General Information
Company Lorus Therapeutics Inc.
DescriptionSmall molecule optimized to increase expression of Kruppel-like factor 4 (KLF4; EZF)
Molecular Target Kruppel-like factor 4 (KLF4) (EZF)
Mechanism of ActionMetal regulatory transcription factor 1 (MTF1) inhibitor
Therapeutic ModalitySmall molecule

 Product Details
Disease CategoryStandard IndicationIndication DetailsPartnersMilestonesLatest Stage of DevelopmentRegulatory Designation
 Archive Items are loading loading
Get a free BioCentury trial today